Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07338851 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study evaluated the antibody persistence of Chinese children five years after they received four doses of sIPV, two doses of MMR vaccine and one dose of HepA-L vaccine.
Trial Details
NCT Number NCT07338851
Lead Sponsor China National Biotec Group Company Limited
Collaborators: Shaanxi Provincial Center for Disease Control and Prevention, Hebei Provincial Center for Disease Control and Prevention, Jiangsu Province Centers for Disease Control and Prevention, Anhui Provincial Center for Disease Control and Prevention, Sichuan Provincial Center for Disease Control and Prevention
Conditions
(from sponsor)		 Polio, Measles, Rubella, Mumps, Hepatitis A
Related terms Hepatitis A, Measles, Mumps, Poliomyelitis, Rubella
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov